Back to top

Image: Shutterstock

Top Ranked Value Stocks to Buy for August 3rd

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, August 3rd:

Cowen Inc. (COWN - Free Report) : This company that provides investment banking, research, sales and trading serives has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.

Cowen has a price-to-earnings ratio (P/E) of 2.52, compared with 16.70 for the industry. The company possesses a Value Score of A.

Garrett Motion Inc. GTX: This turbocharger and electric boosting technologies provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 39.4% over the last 60 days.

Garrett Motion has a price-to-earnings ratio (P/E) of 4.25, compared with 18.50 for the industry. The company possesses a Value Score of A.

Meta Financial Group, Inc. (CASH - Free Report) : This holding company has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 12.4% over the last 60 days.

Meta Financial has a price-to-earnings ratio (P/E) of 6.87, compared with 14.30 for the industry. The company possesses a Value Score of A.

Atlas Air Worldwide Holdings, Inc. (AAWW - Free Report) : This outsourced aircraft and aviation operating services provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.1% over the last 60 days.

Atlas Air Worldwide has a price-to-earnings ratio (P/E) of 6.16, compared with 30.30 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>